(1)
Yang, F.; Guo, W.; Sun, S.; Huang, Y. Combination of Prostate Cancer Antigen 3 (PCA3), Sarcosine, Glypican-1 (GPC1), Urokinase Plasminogen Activator Receptor (uPAR), and Thymidine Kinase 1 (TK1), and T2WI and DWI Radiomics Model for Distinguishing Benign Prostatic Hyperplasia, Prostate Cancer: Prostate Cancer Antigen 3 (PCA3), Sarcosine, Glypican-1 (GPC1), Urokinase Plasminogen Activator Receptor (uPAR), and Thymidine Kinase 1 (TK1), . J Med Biochem 2025, 44 (6), 1376-1385. https://doi.org/10.5937/jomb0-57639.